🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
This research study is studying targeted immunotherapies as a possible trea...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2016-03
Trial ID
NCT02648997
The goal of this clinical research study is to determine whether the PD-1 i...
Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2019-01-30
Trial ID
NCT03347838
Treatments Being Tested
The study's hypothesis is that using Nivolumab as early switch maintenance,...
Status
Unknown
Location
UOC Oncologia - Azienda USL di Imola - Ospedale Santa Maria della Scaletta
Start Date
2017-09-25
Trial ID
NCT03542461
Treatments Being Tested
The purpose of this study is to find out if the addition of nivolumab can i...
Status
Completed
Location
University of Michigan Rogel Cancer Center
Start Date
2019-09-05
Trial ID
NCT03829722
Treatments Being Tested
To investigate the combination of nivolumab and ipilimumab with panitumumab...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2018-03-09
Trial ID
NCT03442569
Treatments Being Tested
This is a phase 1b feasibility study of pre-operative immunotherapy in PD-L...
Status
Completed
Location
Antoni van Leeuwenhoek ziekenhuis
Start Date
2021-08-23
Trial ID
NCT04871594
Treatments Being Tested
This is a multicenter, single-arm, phase II study of nivolumab in combinati...
Status
Active Not Recruiting
Location
Institut Jules Bordet
Start Date
2021-03-25
Trial ID
NCT04503694
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
Cancer - including esophageal squamous cell cancer (ESCC) - is a disease of...
Status
Completed
Location
Universitätsmedizin Mannheim, Heidelberg University, II. Medizinische Klinik
Start Date
2018-02-21
Trial ID
NCT03416244
Treatments Being Tested